These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 24719462)
21. The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes. Bomben R; Gobessi S; Dal Bo M; Volinia S; Marconi D; Tissino E; Benedetti D; Zucchetto A; Rossi D; Gaidano G; Del Poeta G; Laurenti L; Efremov DG; Gattei V Leukemia; 2012 Jul; 26(7):1584-93. PubMed ID: 22343732 [TBL] [Abstract][Full Text] [Related]
24. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells. Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M Leukemia; 2011 May; 25(5):828-37. PubMed ID: 21372840 [TBL] [Abstract][Full Text] [Related]
25. CLL biology and prognosis. Dighiero G Hematology Am Soc Hematol Educ Program; 2005; ():278-84. PubMed ID: 16304392 [TBL] [Abstract][Full Text] [Related]
26. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells. Muzio M; Scielzo C; Bertilaccio MT; Frenquelli M; Ghia P; Caligaris-Cappio F Br J Haematol; 2009 Feb; 144(4):507-16. PubMed ID: 19036098 [TBL] [Abstract][Full Text] [Related]
27. The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells. Dal Bo M; D'Agaro T; Gobessi S; Zucchetto A; Dereani S; Rossi D; Zaja F; Pozzato G; Di Raimondo F; Gaidano G; Laurenti L; Del Poeta G; Efremov DG; Gattei V; Bomben R Oncotarget; 2015 Aug; 6(22):19102-17. PubMed ID: 26036258 [TBL] [Abstract][Full Text] [Related]
28. The role of the B-cell receptor in the pathogenesis of chronic lymphocytic leukaemia. Packham G; Stevenson F Semin Cancer Biol; 2010 Dec; 20(6):391-9. PubMed ID: 20816790 [TBL] [Abstract][Full Text] [Related]
29. The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia. Kipps TJ Best Pract Res Clin Haematol; 2007 Sep; 20(3):415-24. PubMed ID: 17707830 [TBL] [Abstract][Full Text] [Related]
30. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Longo PG; Laurenti L; Gobessi S; Petlickovski A; Pelosi M; Chiusolo P; Sica S; Leone G; Efremov DG Leukemia; 2007 Jan; 21(1):110-20. PubMed ID: 17024114 [TBL] [Abstract][Full Text] [Related]
31. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia. Stevenson FK; Forconi F; Packham G Semin Hematol; 2014 Jul; 51(3):158-67. PubMed ID: 25048780 [TBL] [Abstract][Full Text] [Related]
32. Spatial organization and early signaling of the B-cell receptor in CLL. Shorer Arbel Y; Bronstein Y; Dadosh T; Kamdjou T; Tsuriel S; Shapiro M; Katz BZ; Herishanu Y Front Immunol; 2022; 13():953660. PubMed ID: 36016925 [TBL] [Abstract][Full Text] [Related]
33. Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice. Layer T; Steele A; Goeken JA; Fleenor S; Lenert P Clin Exp Immunol; 2011 Mar; 163(3):392-403. PubMed ID: 21235537 [TBL] [Abstract][Full Text] [Related]
34. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia. Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084 [TBL] [Abstract][Full Text] [Related]
35. CLL cells respond to B-Cell receptor stimulation with a microRNA/mRNA signature associated with MYC activation and cell cycle progression. Pede V; Rombout A; Vermeire J; Naessens E; Mestdagh P; Robberecht N; Vanderstraeten H; Van Roy N; Vandesompele J; Speleman F; Philippé J; Verhasselt B PLoS One; 2013; 8(4):e60275. PubMed ID: 23560086 [TBL] [Abstract][Full Text] [Related]
36. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. Fais F; Ghiotto F; Hashimoto S; Sellars B; Valetto A; Allen SL; Schulman P; Vinciguerra VP; Rai K; Rassenti LZ; Kipps TJ; Dighiero G; Schroeder HW; Ferrarini M; Chiorazzi N J Clin Invest; 1998 Oct; 102(8):1515-25. PubMed ID: 9788964 [TBL] [Abstract][Full Text] [Related]
37. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101 [TBL] [Abstract][Full Text] [Related]
38. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742 [TBL] [Abstract][Full Text] [Related]
39. Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression. Deglesne PA; Chevallier N; Letestu R; Baran-Marszak F; Beitar T; Salanoubat C; Sanhes L; Nataf J; Roger C; Varin-Blank N; Ajchenbaum-Cymbalista F Cancer Res; 2006 Jul; 66(14):7158-66. PubMed ID: 16849562 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. Pawar RD; Ramanjaneyulu A; Kulkarni OP; Lech M; Segerer S; Anders HJ J Am Soc Nephrol; 2007 Jun; 18(6):1721-31. PubMed ID: 17460144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]